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a  b  s  t  r  a  c  t
Most  cells  grown  in glucose-containing  medium  generate  almost  all  their  ATP via glycolysis  despite
abundant  oxygen  supply  and  functional  mitochondria,  a  phenomenon  known  as the  Crabtree  effect.  By
contrast,  most  cells  within  the  body  rely  on  mitochondrial  oxidative  phosphorylation  (OXPHOS)  to gen-
erate  the  bulk of  their  energy  supply.  Thus,  when  utilising  the accessibility  of cell  culture  to  elucidate
fundamental  elements  of mitochondria  in  health  and  disease,  it is  advantageous  to  adopt  culture  con-
ditions  under  which  the cells  have  greater  reliance  upon  OXPHOS  for the  supply  of  their energy needs.
Substituting  galactose  for glucose  in the  culture  medium  can provide  these  conditions,  but additional  ben-
eﬁt can  be gained  from  alternate  in  vitro  models.  Herein  we  describe  culture  conditions  in which  completeactate
xidative phosphorylation (OXPHOS)
lectron transport chain (ETC)
autonomous  depletion  of  medium  glucose  induces  a lactate-consuming  phase  marked  by  increased  Mito-
Tracker Deep  Red  staining  intensity,  increased  expression  of Kreb’s  cycle  proteins,  increased  expression
of  electron  transport  chain  subunits,  and increased  sensitivity  to the  OXPHOS  inhibitor  rotenone.  We
propose  these  culture  conditions  represent  an  alternate  accessible  model  for  the  in vitro  study  of  cellular
processes  and diseases  involving  the  mitochondrion  without  limitations  incurred  via  the  Crabtree  effect.
©  2016  The  Author(s).  Published  by  Elsevier  Ltd. This  is an open  access  article  under  the  CC  BY-NC-ND. Introduction
Glycolysis is an inefﬁcient mechanism for generating ATP rel-
tive to mitochondrial oxidative phosphorylation (OXPHOS) (Lunt
nd Vander Heiden, 2011), and most cells within the body there-
ore rely on OXPHOS to meet the bulk of their energy requirements.
owever, the presence of glucose in commonly used cell culture
onditions favours glycolysis over OXPHOS due to allosteric modu-
ation of glycolytic enzymes by glucose (Rodriguez-Enriquez et al.,
001) and the binding of hexokinase to mitochondrial porin which
ccelerates glycolysis (Golshani-Hebroni and Bessman, 1997). As
 consequence, most cells grown in glucose-containing medium
Abbreviations: AMPK, 5′-adenosine monophosphate-activated protein kinase
lpha; ATP5A, ATP synthase subunit alpha; BCA, bicinchoninic acid; FCCP, carbonyl
yanide p-(triﬂuoromethoxy) phenylhydrazone; COX5B, cytochrome c oxidase
ubunit 5B; 2-DG, 2-deoxyglucose; GAPDH, glyceraldehyde-3-phosphate dehy-
rogenase; OXPHOS, oxidative phosphorylation; PCNA, proliferating cell nuclear
ntigen; pMEFs, primary mouse embryonic ﬁbroblasts; SDHB, succinate dehydro-
enase subunit B; SOD1, superoxide dismutase 1; SOD2, superoxide dismutase 2;
OM20, mitochondrial import receptor subunit TOM20 homolog.
∗ Corresponding author at: Department of Pathology, University of Melbourne,
010, Melbourne, Australia.
E-mail address: pjcrouch@unimelb.edu.au (P.J. Crouch).
ttp://dx.doi.org/10.1016/j.biocel.2016.08.029
357-2725/© 2016 The Author(s). Published by Elsevier Ltd. This is an open access articl
.0/).license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
generate almost all their ATP via glycolysis despite abundant
oxygen supply and the presence of functional mitochondria, a
phenomenon known as the Crabtree effect (Crabtree, 1929). This
phenomenon is not restricted to cells cultured in high glucose-
containing medium (∼20 mM)  but also occurs in cells cultured
in low glucose-containing (∼5 mM)  medium (Rodriguez-Enriquez
et al., 2001).
To enhance extrapolation from cell culture experiments to in
vivo conditions pertaining to energetically demanding cells and/or
conditions arising from decreased mitochondrial function, it is
therefore useful to adapt the cell culture environment such that
cells are less glycolytic and more dependent on OXPHOS. One
way of achieving this is by substituting glucose in the culture
medium with galactose, usually at concentrations of 5–10 mM
(Aguer et al., 2011; Allen et al., 2014; Bird et al., 2014; Dott et al.,
2014; Marroquin et al., 2007; Robinson et al., 1992; Warburg et al.,
1967). The slow oxidation of galactose to pyruvate via glycolysis
forces cells to rely on mitochondrial OXPHOS to generate sufﬁcient
ATP for survival (Dott et al., 2014). Other carbohydrates including
fructose and maltose have been used to replace medium glucose
for the purpose of stabilising medium pH (Imamura et al., 1982)
but these models have not been widely utilised.
To date the galactose model is the most widely used way to cir-
cumvent the Crabtree effect. However, limitations of this model are
e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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ssociated with increased cellular metabolic stress and an acceler-
ted ageing phenotype (Aguer et al., 2011; Barker et al., 1999; Choi
t al., 2013; Coban et al., 2014; Li et al., 2014) and the fact that some
ell types are unable to utilise galactose (Elkalaf et al., 2013). Addi-
ional beneﬁt can therefore be gained from alternate approaches to
vercome limitations associated with the Crabtree effect. Herein
e describe culture conditions in which complete autonomous
epletion of medium glucose forces cells to utilise lactate via mito-
hondrial OXPHOS to supply their energy needs. These conditions
epresent an alternate accessible model for the in vitro study of cel-
ular processes and diseases involving the mitochondrion without
imitations incurred via the Crabtree effect.
. Materials and methods
.1. Materials
Cell culture reagents were from Life Technologies and chemicals
ere from Sigma-Aldrich unless otherwise speciﬁed.
.2. Cell culture conditions
Primary mouse embryonic ﬁbroblasts (pMEFs) were obtained
rom E14 C57BL/6 mice as previously described (Garﬁeld, 2010).
t passage 1 cells were frozen and stored in liquid nitrogen. For
ach experiment cells were thawed then allowed to reach con-
uency, then passaged and seeded into 24-well plates (Nunc) at
 × 104 cells/cm2 in DMEM containing 3.5 mM glucose and sup-
lemented with 10% (v/v) foetal bovine serum, 50 U/mL penicillin,
0 g/mL streptomycin, 1 mM  L-glutamine, and 9.7 mM mannitol
Ajax Finechem). Cultures were maintained at 37 ◦C in a humidiﬁed
ncubator with 5% CO2.
Primary adult human ﬁbroblasts were obtained from superﬁcial
kin biopsies of the right inner forearm of a healthy person as pre-
iously reported (Solski et al., 2012). All culture conditions were as
escribed above for the pMEFs.
Primary mouse brain astrocytes were obtained from new born
57BL/6 pups as previously described (Hare et al., 2013). Cells were
eeded into 48-well plates at 15 × 104 cells/cm2 and allowed to
each maturity until day 15. Experiments were commenced on day
5 (thereafter referred to as experimental day 0) when the medium
as replaced with DMEM containing 5.0 mM glucose and supple-
ented with 10% (v/v) foetal bovine serum, 50 U/mL penicillin, and
0 g/mL streptomycin. Cultures were maintained at 37 ◦C in a
umidiﬁed incubator with 10% CO2.
These three cell types were chosen based on their versatility to
anipulations in culture conditions. For all cell types the volume
f media used was equivalent to 20 mL  per T75 ﬂask (266 L/cm2).
ll mouse work was approved by the University of Melbourne
iosciences Animal Ethics Committee. All human cell work was
pproved by the University of Melbourne Biosciences Human Ethics
ommittee.
.3. Lactate and glucose content of cell culture medium
Lactate and glucose levels in the cell culture medium were deter-
ined using methods based on those previously described (Liddell
t al., 2009). Aliquots of medium were collected from the cell cul-
ures at the start of the culture period (day 0) then further aliquots
ollected once daily for 7 days (pMEFs) or 13 days (human ﬁbrob-
asts). For astrocyte cultures medium aliquots were collected on
ays 0, 0.25, 1, and 5. Modiﬁcations made to the protocols described
y Liddell et al. (2009) involved the use of glucose and lactate stan-
ard curves instead of extinction coefﬁcients.emistry & Cell Biology 79 (2016) 128–138 129
2.4. BCA assay for quantiﬁcation of protein content
Total protein levels within each well of the culture plates
were measured at each medium collection time point (once daily,
on days 0–7) for the pMEFs. For all cell types protein levels
were measured at the completion of all 2-deoxyglucose (2-DG)
or rotenone treatments. Results are expressed relative to vehicle
control treated cells to account for differences in cell conﬂuency
between glucose-consuming and lactate-consuming phases. Fol-
lowing medium collection, cells were washed twice with chilled
PBS. Protein was solubilised using 300 L per well of 100 mM NaOH
and incubated on an orbital shaker at room temperature for 2 h.
Protein concentration was measured using a Bicinchoninic Acid
(BCA) Assay Kit (Thermo Scientiﬁc) by comparison to a bovine
serum albumin standard curve, as per manufacturer instructions.
While protein content is inﬂuenced by a multitude of factors, robust
changes in total cellular protein are a good indicator of both cell
proliferation and cell viability (Engelhard et al., 1991; Vichai and
Kirtikara, 2006).
2.5. Phase contrast microscopy
Phase contrast microscopy was used to monitor changes in
pMEF conﬂuency and morphology daily during the experiment
(days 0–7). Representative images of the cells were taken using
a light microscope and a Canon Powershot A2300 digital camera
on day 1 (glucose-consuming phase) and day 5 (lactate-consuming
phase).
2.6. Western blotting for protein analyses
pMEFs grown in T75 ﬂasks (Nunc) were pelleted (720 RCF,
3 min) and lysed in PhosphoSafe Extraction Buffer (Merck) supple-
mented with 1 mM phenylmethyl sulphonyl ﬂuoride (PMSF) and
1.6 mM deoxyribonuclease I from bovine pancreas (DNase I, Roche).
Following centrifugation (15,000 RCF, 3 min), lysates at equal pro-
tein concentration were mixed with 4 x gel loading buffer [250 mM
Tris, 20% (v/v) glycerol, 8% (w/v) SDS, 2% (v/v) -mercaptoethanol,
0.01% (w/v) bromophenol blue] then heated at 95 ◦C for 5 min.
Denatured and reduced proteins were separated on 4–12% Bis Tris
gels (NuPage) at 200 V for 42 min. Resolved proteins were trans-
ferred onto PVDF membranes at 20 V for 7 min  using the iBlot
transfer system (Invitrogen). PVDF membranes were blocked with
PBST [PBS supplemented with 0.05% (v/v) Tween-20] containing
4% (w/v) skim milk powder. Membranes were incubated with pri-
mary antibody overnight at 4 ◦C then secondary antibody for 2 h at
room temperature before visualising chemiluminescence of pro-
tein bands using ECL Advance (GE Healthcare) and a MicroChemi
imager (DNR Bio-Imaging Systems). Primary antibodies to prolifer-
ating cell nuclear antigen (Cell Signaling #2586, 1:1500), citrate
synthase (Abcam #ab96600, 1:800), cytochrome c oxidase sub-
unit 5 B (Abcam #ab180136, 1:600), ATP synthase subunit alpha
(Abcam #ab176569, 1:600), succinate dehydrogenase subunit B
(Abcam #ab175225, 1:600), mitochondrial import receptor subunit
TOM20 homolog (Protein Tech #11802-1-AP, 1:600), superoxide
dismutase 2 (Abcam #ab13533, 1:5000), superoxide dismutase
1 (Abnova #PAB0725, 1:2000), phospho(Thr172)-5′-adenosine
monophosphate-activated protein kinase alpha (Cell Signaling
#2535, 1:400), 5′-adenosine monophosphate-activated protein
kinase alpha (Cell Signaling #2532, 1:600), and glyceraldehyde-
3-phosphate dehydrogenase (Cell Signaling #2118, 1:5000) were
used. HRP-linked anti-rabbit IgG (Cell Signaling #7074, 1:5000)
and HRP-linked anti-mouse IgG (Cell Signaling #7076, 1:5000) sec-
ondary antibodies were used. Relative abundance of proteins was
determined using ImageJ 1.38 × software.
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.7. Fluorescence microscopy
pMEFs on coverslips were stained with the mitochondrial-
peciﬁc dye MitoTracker Deep Red FM (Molecular Probes
M22426) or the primary antibody to mitochondrial import recep-
or subunit TOM20 homolog (TOM20, ProteinTech #11802-1-AP)
n day 1 (glucose-consuming phase) and day 5 (lactate-consuming
hase). Existing medium was supplemented with 500 nM Mito-
racker Deep Red for 20 min  at 37 ◦C in a humidiﬁed incubator
ith 5% CO2. Cells were then ﬁxed in 4% (w/v) paraformaldehyde
Electron Microscopy Sciences) for 20 min  at room temperature.
ixed cells were permeabilised in 0.2% (v/v) Triton X-100 for 10 min
t room temperature. Following blocking in PBS supplemented
ith 0.3% (v/v) Triton X-100 and 1% (w/v) bovine serum albu-
in, cells were incubated with primary TOM20 antibody (overnight
t 4 ◦C), followed by ﬂuorescently-tagged secondary anti-rabbit
lexa Fluor 568 antibody for 2 h at room temperature. All cells
ere stained with the nuclear stain DAPI (5 min  at room tem-
erature). MitoTracker Deep Red stained cells were imaged by
aking single 1.0 m thick images using a confocal microscope
Zeiss LSM Meta) and Zen imaging software. TOM20 stained cells
ere imaged using an AxioCam HR camera mounted onto a Leica
nverted Fluorescence microscope. Speciﬁcity of TOM20 mitochon-
rial staining was conﬁrmed using confocal microscopy. To allow
or quantitative comparisons between days 1 and 5 to be made, all
overslips were imaged using identical exposure times and laser
ower settings. Staining intensity (per cellular area) was obtained
sing ImageJ 1.38 × software. Brieﬂy, cell nuclei masks (based on
API staining) were subtracted from total cellular area masks,
fter which staining intensity for the cytoplasmic area was quanti-
ed. To conﬁrm that mitochondrial accumulation of MitoTracker
eep Red is dependent on mitochondrial membrane potential,
MEFs were treated with the mitochondrial depolarisation com-
ound carbonyl cyanide p-(triﬂuoromethoxy) phenylhydrazone
FCCP) at 5 M for 15 min  in existing medium prior to incubation
ith MitoTracker Deep Red as above. Cells were then co-stained
ith TOM20 antibody and ﬂuorescently-tagged secondary Alexa
luor 488 antibody. All other aspects were as above, except that
itoTracker Deep Red staining intensity within mitochondria was
uantiﬁed using TOM20 to generate a mask of the mitochondrial
rea.
.8. Cell treatments with metabolic inhibitors
pMEFs were treated with the glycolysis inhibitor 2-
eoxyglucose (2-DG; 5 mM)  or vehicle control for 24 h on
ay 1 (glucose-consuming phase) and day 5 (lactate-consuming
hase). All cell types were treated with the mitochondrial complex
 inhibitor rotenone at concentrations and treatment durations
ptimised for each cell type. pMEFs were treated with 100 M
otenone for 4 h on days 1 and 5. Astrocytes were treated with
0 nM rotenone for 6 h on day 0 (glucose-consuming phase) and
ay 5 (lactate-consuming phase). Human ﬁbroblasts were treated
ith 2 M rotenone for 16 h on day 3 (glucose-consuming phase)
nd day 13 (lactate-consuming phase). All cells were treated with
ither 2-DG/rotenone or vehicle control by supplementing the
xisting medium.
.9. Cell viability MTT  and LDH assays
Viability of 2-DG or rotenone treated cells was analysed using
he MTT  reduction and the LDH release assays. MTT  was  added to
he existing culture medium at 480 M for 1 h. After removal of
he medium the MTT  was solubilised in DMSO. The increase in
bsorbance at 560 nm was  standardised to vehicle treated cells
o account for differences in cell conﬂuency between glucose-emistry & Cell Biology 79 (2016) 128–138
consuming and lactate-consuming phases. Extracellular lactate
dehydrogenase (LDH) activity was determined using the LDH Cyto-
toxicity Detection Kit (Roche), as per manufactures instructions.
Values were standardised to cells lysed in medium containing 1%
(v/v) Triton X-100.
2.10. Statistical analyses
All experiments were performed with at least 3 independent
repeats (n = 3) using separate cell culture samples. All data shown in
graphical representations are mean values ± standard error of the
mean (SEM). Statistical analyses were performed using two-way
ANOVA with Bonferroni secondary testing and unpaired Students t-
test (two-tailed) as appropriate. P-values of <0.05 were considered
statistically signiﬁcant. GraphPad Prism 5 software was used for all
analyses.
3. Results
3.1. Depletion of medium glucose induces lactate consumption in
cultured pMEFs
Under the culture conditions described, monitoring the glucose
and lactate content of the pMEF culture medium revealed an initial
glucose-consuming phase associated with lactate accumulation in
the medium (day 0 to day 3), indicating a predominantly glycolytic
phenotype (Fig. 1A). Then, once glucose in the medium had been
depleted, lactate in the medium progressively declined (day 3 to
day 7) indicating the cells had entered a lactate-consuming phase
marked by increased reliance on mitochondrial oxidative phospho-
rylation (Fig. 1A). Protein levels per well, used as a surrogate marker
of cell proliferation (Engelhard et al., 1991), increased rapidly dur-
ing the glucose-consuming phase but then slowed once the cells
entered the lactate-consuming phase (Fig. 1B). Consistent with
this, the transition from glucose-consuming to lactate-consuming
was accompanied by a marked decrease in protein expression
of proliferating cell nuclear antigen (PCNA, Fig. 1C), an estab-
lished marker of cell proliferation (Wang, 2014). Phase contrast
images indicated relatively consistent pMEF morphology in both
phases of the study period, despite variations in cell density
(Fig. 1D).
3.2. Increased markers of mitochondrial OXPHOS during the
lactate-consuming phase
The switch from net lactate production during the glucose-
consuming phase to net lactate consumption once available glucose
had been depleted from the culture medium (Fig. 1A) indicates an
increased reliance on mitochondrial OXPHOS. To test this possibil-
ity, cells were exposed to the ﬂuorescent probe MitoTracker Deep
Red. Mitochondrial retention of MitoTracker Deep Red is depen-
dent upon mitochondrial membrane potential (Hallap et al., 2005;
Nakahira et al., 2011), and can therefore be predicted to increase in
cells with increased OXPHOS. MitoTracker Deep Red ﬂuorescence
intensity increased 7-fold in pMEFs in the lactate-consuming phase
when compared to cells in the glucose-consuming phase (Fig. 2A).
By contrast, immunostaining for mitochondrial import receptor
subunit TOM20 homolog (TOM20, Fig. 2B) and TOM20 western blot
analyses (Fig. 2C) showed relative consistency, indicating that the
observed increase in MitoTracker Deep Red ﬂuorescence is not sim-
ply due to an overall increase in mitochondrial mass (Burbulla et al.,
2014). To conﬁrm that mitochondrial accumulation of MitoTracker
Deep Red is dependent on mitochondrial membrane potential,
pMEFs were treated with the mitochondrial depolarisation com-
pound carbonyl cyanide p-(triﬂuoromethoxy) phenylhydrazone
A.I. Mot et al. / The International Journal of Biochemistry & Cell Biology 79 (2016) 128–138 131
Fig. 1. Effects of medium glucose depletion on pMEF cell growth and morphology.
(A)  Glucose and lactate concentration in culture medium showing two  phases of growth: a glucose-consuming (glycolytic) phase during days 0–3 followed by a lactate-
consuming (OXPHOS) phase. Vertical dashed lines indicate the point at which glucose in the medium is depleted. (B) Total protein content measured daily using the BCA
assay.  (C) Proliferating cell nuclear antigen (PCNA) levels determined by western blot for glucose-consuming cells (“Glc”, day 1) and lactate-consuming cells (“Lac”, day 5).
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hen  compared to glucose-consuming cells on day 1, unpaired Students t-test (n =
FCCP). Treating with FCCP decreased MitoTracker Deep Red stain-
ng intensity within the mitochondrial area (Fig. 3).
To further explore the possibility that OXPHOS is increased in
MEFs in the lactate-consuming phase, cell extracts were assessed
or components of the Kreb’s cycle and mitochondrial electron
ransport chain. These analyses revealed levels of citrate synthase,
ytochrome c oxidase subunit 5 B (COX-5B), ATP synthase subunit
lpha (ATP5A) and succinate dehydrogenase subunit B (SDHB) are
ll increased in pMEFs in the lactate-consuming phase (Fig. 4A-D).
hese changes are consistent with increased ﬂux through the path-
ays needed to support OXPHOS in the lactate-consuming phase.
iven the role for superoxide dismutase 2 (SOD2) in detoxifying
itochondrial reactive oxygen species (Flynn and Melov, 2013),
ncreased expression of SOD2 in the lactate-consuming phase
Fig. 4E) is also consistent with increased ﬂux through the electron
ransport chain. The absence of any changes to cytosolic SOD1 lev-
ls (Fig. 4F) indicates the changes to SOD2 are not due to a relatively
eneric increase in cellular oxidative stress associated with the
ransition from glucose-consuming to lactate-consuming. More-
ver, levels of activated AMPK were also unchanged (Fig. 4G).
MPK is activated via phosphorylation at Thr172 in response
o cellular energy stress (Viollet et al., 2010). Thus, the absence
f any change to activated AMPK indicates that the pMEFs
re not under cellular energy stress in the lactate-consuming
hase.essed relative to day 1 cells. (D) Representative phase contrast microscopy images
d lactate-consuming cells (“Lac phase”, day 5). Scale bar = 25 m.  * Denotes p < 0.05
3.3. Cells in the lactate-consuming phase are more sensitive to
rotenone
Supporting the notion that pMEFs in the glucose-consuming
phase rely predominantly on glycolysis to meet their energy needs
and cells in the lactate-consuming phase rely predominantly on
OXPHOS, we found the cells displayed differential sensitivity to the
inhibitors 2-DG and rotenone. Exposure to the glycolysis inhibitor
2-DG induced signiﬁcant changes to MTT  reduction and protein
content per well when pMEFs were in the glucose-consuming
phase yet had relatively little impact on pMEFs during the lactate-
consuming phase (Fig. 5A and B). By contrast, exposing pMEFs to the
OXPHOS inhibitor rotenone had a greater impact on MTT  reduction,
protein content per well and LDH release in the lactate-consuming
phase when compared to pMEFs in the glucose-consuming phase
(Fig. 5C–E). To assess whether results obtained from pMEFs could
be recapitulated in other cell types, primary adult human skin
ﬁbroblasts and primary mouse brain astrocytes were also used
to model the glucose-consuming and lactate-consuming phases.
Speciﬁc culture conditions varied across the three cell types exam-
ined (as described in the Materials and Methods), but once these
conditions were established the delineation between glucose-
consuming and lactate-consuming was identiﬁed (Fig. 6A and D).
Consistent with results obtained from the pMEFs, the mouse brain
astrocytes (Fig. 6B and C) and the adult human skin ﬁbroblasts
132 A.I. Mot et al. / The International Journal of Biochemistry & Cell Biology 79 (2016) 128–138
Fig. 2. MitoTracker Deep Red and TOM20 staining intensity in glucose-consuming and lactate-consuming pMEFs.
Fluorescence microscopy images showing cellular distribution of (A) a mitochondria-speciﬁc dye MitoTracker Deep Red and (B) the mitochondrial import receptor subunit
TOM20  homolog (TOM20). All cells were counter stained for nuclei using DAPI (blue) and representative images for glucose-consuming cells (“Glc phase”, day 1) and lactate-
consuming cells (“Lac phase”, day 5) taken using confocal microscopy and Zen imaging software. All cells were imaged using identical exposure times and laser power
settings. Scale bar = 15 m in A and 10 m in B. Quantitation of MitoTracker Deep Red was derived from confocal images and quantitation of TOM20 was derived from
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Fig. 6E and F) displayed higher sensitivity to rotenone during the
actate-consuming phase.
. Discussion
Although glycolysis is relatively inefﬁcient at generating ATP
hen compared to OXPHOS, this inefﬁciency can be offset by
ramatically accelerating ﬂux rates through the glycolytic path-
ay (Marroquin et al., 2007). Indeed, this is a central tenet of
he Crabtree effect (Crabtree, 1929) whereby cells cultured in
lucose-containing medium preferentially produce ATP via gly-
olysis despite an abundant supply of oxygen and the presence
f functional mitochondria. Thus many cell types, including can-
er cells, embryonically-derived cells and proliferating thymocytes,
cquire highly glycolytic phenotypes when cultured in glucose-
ontaining medium (Guppy et al., 1993; Marroquin et al., 2007;
ossignol et al., 2004; Seshagiri and Bavister, 1991). This has sig-
iﬁcant implications for cell culture studies that aim to investigate
itochondria-related processes in vitro because, unlike most cells
n the body, cells grown in standard culture medium can readily
urvive independently of mitochondrial OXPHOS. A salient exam-
le of this is evident in rho0 cells; these cells have no capacity for
XPHOS due to depletion of mitochondrial DNA yet can be grown
n culture medium supplemented with sufﬁcient glucose (King
nd Attardi, 1996). The highly glycolytic nature of cells cultured
n glucose-containing medium therefore limits the utility of cell
ulture to accurately study some mitochondria-related processes
n vitro.ming cells (“Glc”, day 1) and lactate-consuming cells (“Lac”, day 5). Densitometry
o day 1 cells. * Denotes p < 0.05 when compared to glucose-consuming cells on day
The present study aimed to circumvent the Crabtree effect by
developing an alternate in vitro model in which cells are required
to rely on mitochondrial OXPHOS to meet their energy needs. To
achieve this, pMEFs were grown in low glucose (3.5 mM)  conditions
and two phases of growth were identiﬁed: the initial glucose-
consuming (glycolytic) phase followed by the lactate-consuming
(OXPHOS) phase (Fig. 1A). The high rate of net lactate produc-
tion compared to glucose consumption during the glycolytic phase
indicates that the cells were converting almost all of the pyru-
vate generated during glycolysis to lactate and exporting it to
the medium rather than utilising the pyruvate in mitochondrial
OXPHOS (Zwingmann and Leibfritz, 2003). While the number of
days required to consume all available medium glucose varied
between the cell types studied, presumably due to intrinsic dif-
ferences in metabolic and growth rates, none of the three cell
types exhibited net lactate consumption until after all the avail-
able glucose had been depleted (Fig. 1A, 6A and 6D). This indicates
that under the conditions examined these cells retain a pre-
dominantly glycolytic phenotype, in preference to OXPHOS, until
glucose is no longer available. It therefore appears that the switch
to dependence upon OXPHOS in these cells under the cell cul-
ture conditions described requires depletion of glucose from the
medium, a condition likely to incur its own limitations. For exam-
ple, glucose metabolism provides essential precursors for chemical
constituents required for cell division (Hume and Weidemann,
1979; Vander Heiden et al., 2009) and the absence of glucose
metabolism is therefore likely to have contributed to the observed
cessation in cell proliferation once glucose in the medium had been
depleted (Fig. 1B and C). Thus, utility of this cell culture model as
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Fig. 3. Effects of the mitochondrial depolarisation compound FCCP on MitoTracker Deep Red staining intensity in pMEFs.
(A)  Fluorescence microscopy images showing cellular distribution of the mitochondria-speciﬁc dye MitoTracker Deep Red (red) and the mitochondrial import receptor subunit
TOM20 homolog (TOM20, green). All cells were counter stained for nuclei using DAPI (blue) and representative images for control and carbonyl cyanide p-(triﬂuoromethoxy)
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rea  and staining intensity is expressed relative to control cells. * Denotes p < 0.05 w
n alternate model to avoid limitations of the Crabtree effect is
till dependent upon the initial glucose-consuming glycolytic phase
uring which the cells proliferate to sufﬁcient levels to support
ubsequent analyses.
These limitations are avoided in the galactose model in which
lycolytic pathways can still support cell proliferation while the
low oxidation of galactose to pyruvate drives dependence upon
XPHOS, as indicated by decreased medium lactate levels in galac-
ose cultured cells (Aguer et al., 2011; Altamirano et al., 2006).
owever, culturing cells in galactose can introduce alternate limi-
ations. For example, some cell types (e.g. skeletal muscle cells) are
nable to metabolise galactose (Elkalaf et al., 2013; Mailloux and
arper, 2010) and galactose can induce an accelerated ageing phe-
otype in both in vitro and in vivo contexts (Barker et al., 1999; Choi
t al., 2013; Coban et al., 2014; Li et al., 2014). Further to this, AMPK
s recognised for its central role in regulating cellular energy levels
ia phosphorylation at Thr172 in response to cellular energy stress
Viollet et al., 2010), and previous studies have shown increased
AMPK in galactose cultured cells, suggesting that galactose in
he medium can induce a state of cellular energy stress (Aguer
t al., 2011). By contrast, the current study shows pAMPK levels
re unchanged in the lactate-consuming phase (Fig. 4G), suggest-
ng that the predominately oxidative cells in this phase are underg software. All cells were imaged using identical exposure times and laser power
 mitochondria was quantiﬁed using TOM20 to generate a mask of the mitochondrial
ompared to control cells, unpaired Students t-test (n = 3).
no additional cellular energy stress when compared to cells in the
glucose-consuming phase.
Mitochondrial uptake and retention of the ﬂuorescent probe
MitoTracker Deep Red is inﬂuenced by mitochondrial membrane
potential and the reducing environment of active mitochondria
(Hallap et al., 2005; Nakahira et al., 2011). Relative to TOM20
levels, which indicated total mitochondrial mass (Burbulla et al.,
2014) within the cells was  not affected by the transition from the
glucose-consuming phase to the lactate-consuming phase (Fig. 2B
and C), MitoTracker Deep Red staining indicated a substantial
increase in mitochondrial membrane potential during the lactate-
consuming phase (Fig. 2A). These data suggest that increased
MitoTracker Deep Red staining intensity in the lactate-consuming
cells is not confounded by changes in mitochondrial mass and
that mitochondria during the lactate-consuming phase are rela-
tively more active when compared to the mitochondria during the
glucose-consuming phase. Moreover, the 7-fold increase in Mito-
Tracker Deep Red staining intensity observed when cells switched
from glucose-consuming to lactate-consuming (Fig. 2A) appears to
exceed the magnitude in changes to membrane potential measured
when cells cultured in glucose-containing medium are exposed to
conditions expected to have a strong impact upon mitochondrial
membrane potential (Appleby et al., 1999; Buchet and Godinot,
1998). Thus, monitoring changes to mitochondrial functionality,
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Fig. 4. Expression of mitochondrial proteins and AMPK in glucose-consuming and lactate-consuming pMEFs.
(A)  Citrate synthase levels, (B) cytochrome c oxidase subunit 5 B (COX-5B) levels, (C) ATP synthase subunit alpha (ATP5A) levels, (D) succinate dehydrogenase subunit B (SDHB)
levels,  (E) superoxide dismutase 2 (SOD2) levels, (F) superoxide dismutase 1 (SOD1) levels, (G) phosphorylated (Thr172) 5′-adenosine monophosphate-activated protein
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ensitometry values are normalised to levels of the GAPDH loading control and are e
ells  on day 1, unpaired Students t-test (n = 3-4).
uch as changes to membrane potential, appears to be substantially
nﬂuenced by whether or not the cells are primarily consuming
ubstrates that favour reliance on glycolysis over OXPHOS.
Increased mitochondrial membrane potential in the lactate-
onsuming phase is consistent with increased expression of
lectron transport chain subunit proteins COX5B, ATP5A, and SDHB
Fig. 4B, C and D) and previous studies that have demonstrated
uppressed OXPHOS in glucose cultured cells (Golshani-Hebroni
nd Bessman, 1997; Rodriguez-Enriquez et al., 2001). COX5B plays
 crucial role in complex IV assembly and expression levels of
his protein are related to mitochondrial membrane potential and
itochondrial ability to generate ATP, such that COX5B deﬁcient
ells are unable to grow in galactose-containing medium (Galati
t al., 2009). ATP5A forms part of the catalytic core of ATP syn-
hase, which plays a central role in controlling ﬂux through the
xidative phosphorylation pathway (Nilsson and Nielsen, 2016).
ikewise, increased SDHB expression levels (Fig. 4D) are associated
ith increased mitochondrial ATP production (Matsumoto et al.,
012), and increased expression of citrate synthase (Fig. 4A), a pace-
aking enzyme of the Krebs cycle, is consistent with increased
itrate synthase activity seen in galactose cultured cells (Aguerglucose-consuming cells (“Glc”, day 1) and lactate-consuming cells (“Lac”, day 5).
sed relative to day 1 cells. * Denotes p < 0.05 when compared to glucose-consuming
et al., 2011). These data are also consistent with increased SOD2
expression levels seen in lactate-consuming cells (Fig. 4E), given the
role for SOD2 in detoxifying reactive oxygen species within mito-
chondria (Flynn and Melov, 2013) and previous studies which have
reported lower levels of SOD2 in glycolytic cancer cells (Bize et al.,
1980).
A metabolic switch from reliance on glycolysis during the
glucose-consuming phase to reliance on OXPHOS during the
lactate-consuming phase is supported by the heightened sensi-
tivity of glucose-consuming cells to the glycolysis inhibitor 2-DG
(Fig. 5A and B) and increased sensitivity of lactate-consuming cells
to the OXPHOS inhibitor rotenone (Figs. 5C, D, E, 6B, C, E and F).
These data demonstrate that despite differences in tissue of ori-
gin (central nervous system versus periphery) or species of origin,
all cell types examined showed signiﬁcantly increased sensitivity
to an OXPHOS inhibitor during the lactate-consuming phase. This
indicates the potential utility of this model when assessing com-
pounds that may  have mitochondrial toxic properties; in order to
gain full understanding of a compound that may exhibit inhibitory
activity towards mitochondrial ATP generation it will be pertinent
A.I. Mot et al. / The International Journal of Biochemistry & Cell Biology 79 (2016) 128–138 135
Fig. 5. Effects of the glycolysis inhibitor 2-deoxyglucose and the OXPHOS inhibitor rotenone on pMEFs under glucose-consuming and lactate-consuming culture conditions.
Effects  of the glycolysis inhibitor 2-deoxyglucose (2-DG, 5 mM,  24 h) on glucose-consuming (“Glc phase”, day 1) and lactate-consuming (“Lac phase”, day 5) pMEFs assessed
using  (A) cell viability MTT  reduction assay and (B) total protein per well. Effects of the OXPHOS inhibitor rotenone (100 M, 4 h) on glucose-consuming (“Glc phase”, day 1)
and  lactate-consuming (“Lac phase”, day 5) pMEFs assessed using (C) cell viability MTT  reduction assay, (D) total protein per well and (E) cell viability LDH release assay. Data
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otal  LDH released following lysis with Triton X-100 where hashed bars indicate ve
 < 0.05 when compared to glucose-consuming cells on day 1, unpaired Students (n
o use cells with a higher dependence upon OXPHOS than cells that
re primarily glycolytic (Dott et al., 2014; Marroquin et al., 2007).
An additional potential utility of this model may  relate to mim-
cking the energy metabolism of cells which, in vivo, have higher
nergy requirements relative to other cells. As an example, neu-
ons in the central nervous system are more inherently reliant
pon OXPHOS for the supply of their energy needs with very
imited capacity to up-regulate glycolysis (Belanger et al., 2011;
errero-Mendez et al., 2009). According to the astrocyte-neuron
actate shuttle hypothesis (ANLSH), the high energy demand of neu-
ons is supported by astrocytes which supply neurons with lactate
Pellerin et al., 2007). Similarly, recent studies show that oligoden-
rocytes also metabolically support neurons in vivo (Funfschillingsuming or lactate-consuming phases of growth. Data in E are expressed relative to
ontrol treated cells and non-hashed bars indicate rotenone treated cells. * Denotes
 for A–D or two-way ANOVA with Bonferroni secondary testing (n = 8) for E.
et al., 2012; Lee et al., 2012). Thus, the lactate-consuming phase
of this model may  have some utility in replicating the in vivo
reliance of neurons on lactate. Furthermore, a recent study has
shown that differentiation of pluripotent stem cells into motor neu-
rons involves a decrease in glycolytic ﬂux and increased expression
of mitochondrial respiratory chain subunits despite no apparent
change in overall mitochondrial mass (O’Brien et al., 2015). The
latter of these observations is consistent with the increase in Mito-
Tracker Deep Red ﬂuorescence intensity in the lactate-consuming
pMEFs despite no change in TOM20 levels (Fig. 2). Conversely,
reprograming somatic cells into induced pluripotent stem cells
requires a shift from oxidative to glycolytic metabolism (Mathieu
et al., 2014). These results therefore highlight the importance of
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Fig. 6. Effects of the OXPHOS inhibitor rotenone on multiple cell types under glucose-consuming and lactate-consuming culture conditions.
(A)  Glucose and lactate concentration in the culture medium of primary mouse brain astrocytes showing a glucose-consuming phase during days 0–1 followed by a lactate-
consuming phase. Effects of the OXPHOS inhibitor rotenone (50 nM,  6 h) on glucose-consuming (“Glc phase”, day 0) and lactate-consuming (“Lac phase”, day 5) astrocytes
assessed using (B) cell viability MTT  reduction assay and (C) total protein per well. (D) Glucose and lactate concentration in the culture medium of primary adult human skin
ﬁbroblasts showing a glucose-consuming phase during days 0–8 followed by a lactate-consuming phase. Effects of rotenone (2 M,  16 h) on glucose-consuming (“Glc phase”,
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ndicate the point at which glucose in medium is depleted. Data in B–C and E–F are 
actate-consuming phases of growth. * Denotes p < 0.05 when compared to glucose
onsidering the metabolic state of cells (glycolytic vs. oxidative) not
nly when attempting to investigate conditions with an expected
mmediate impact upon mitochondrial function (e.g. toxin studies)
ut also when investigating cell types known to have a naturally
igher oxidative metabolic phenotype.
. ConclusionHerein are described in vitro cell culture conditions in which
ell autonomous depletion of glucose from the culture medium
orces cells to utilise lactate via mitochondrial OXPHOS to supply
heir energy needs. While this model presents its own  considerableell viability MTT  reduction assay and (F) total protein per well. Vertical dashed lines
ssed relative to vehicle control treated cells at the respective glucose-consuming or
ming cells on day 1, unpaired Students (n = 3-6).
caveats (i.e. reliance upon complete depletion of glucose from the
medium) and does not address other signiﬁcant non-physiological
elements of culturing cells under commonly used conditions (e.g.
atmospheric oxygen concentrations), it nonetheless provides alter-
nate opportunity to study cellular processes and diseases involving
the mitochondrion without limitations incurred via the Crabtree
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